Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2019

05.03.2019 | Gynecologic Oncology

Compare two different usages of FRD for detecting high-grade cervical lesions and invasive cancer

verfasst von: Yuping Dai, Lirong Wang, Donghong Li

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate two usages of the folate receptor-mediated staining solution (FRD) for detecting high-grade cervical lesions and invasive cancer, and compared with cytology test (TCT) and human papillomavirus (HPV) testing.

Methods

FRD sampling and FRD direct staining methods were used for detecting high-grade cervical lesions and invasive cancer. As a comparison, TCT and HPV testing were also applied for screening high-grade cervical lesions and invasive cancer. The sensitivity and specificity of TCT, HPV testing, and staining results of FRD were analyzed by the SPSS software.

Results

In this study, 317 patients with biopsy were collected. The positive rate of FRD sampling method was 35.33% (112/317), and positive rate of FRD direct staining was 48.90% (155/317). Area under the curve (AUC) of TCT, HPV testing, FRD sampling and FRD direct staining were 0.53, 0.55, 0.58, and 0.75, respectively. The sensitivity of TCT, HPV, FRD sampling and FRD direct staining was 69.72%, 97.25%, 64.22% and 81.65%, respectively, and the specificity was 37.98%, 12.98%, 79.81% and 68.27%, respectively.

Conclusion

Compared with TCT and HPV testing, two usages of FRD methods have compatible sensitivity and high specificity to detect high-grade cervical lesions and invasive cancer. FRD direct staining may be comfortable for routine cervical cancer screening
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics, 2012. CA Cancer J Clin 61:69–90CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics, 2012. CA Cancer J Clin 61:69–90CrossRef
3.
Zurück zum Zitat Hu Z, Zhu D, Wang W et al (2015) Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet 47:158CrossRefPubMed Hu Z, Zhu D, Wang W et al (2015) Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet 47:158CrossRefPubMed
4.
Zurück zum Zitat Organization WH (2005) IARC handbooks of cancer prevention, vol 10. Cervix cancer screening, pp 117–120. Organization WH (2005) IARC handbooks of cancer prevention, vol 10. Cervix cancer screening, pp 117–120.
5.
Zurück zum Zitat Berkhof J, Meijer CJ (2007) Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N Engl J Med 358:642 (author reply 3) Berkhof J, Meijer CJ (2007) Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N Engl J Med 358:642 (author reply 3)
6.
Zurück zum Zitat Naucler P, Ryd W, Törnberg S et al (2008) Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357:1589CrossRef Naucler P, Ryd W, Törnberg S et al (2008) Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357:1589CrossRef
7.
Zurück zum Zitat Nanda K, Mccrory DC, Myers ER et al (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132:810CrossRefPubMed Nanda K, Mccrory DC, Myers ER et al (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132:810CrossRefPubMed
8.
Zurück zum Zitat Staples M (2014) HPV-based screening for prevention of invasive cervical cancer. Lancet 383:1294CrossRef Staples M (2014) HPV-based screening for prevention of invasive cervical cancer. Lancet 383:1294CrossRef
9.
Zurück zum Zitat Zhang CH, Xue XL, Dang RF, Gynecology DO (2014) Application value of folate receptor mediated FRD in diagnosis of cervical intraepithelial neoplasia and cancer. Chin J Lab Diagn 8:7830–7836 Zhang CH, Xue XL, Dang RF, Gynecology DO (2014) Application value of folate receptor mediated FRD in diagnosis of cervical intraepithelial neoplasia and cancer. Chin J Lab Diagn 8:7830–7836
10.
Zurück zum Zitat Lu MH, Hu LY, Du XX et al (2014) An special epithelial staining agents: folic acid receptor-mediated diagnosis (FRD) effectively and conveniently screen patients with cervical cancer. Int J Clin Exp Med 8:7830 Lu MH, Hu LY, Du XX et al (2014) An special epithelial staining agents: folic acid receptor-mediated diagnosis (FRD) effectively and conveniently screen patients with cervical cancer. Int J Clin Exp Med 8:7830
11.
Zurück zum Zitat Anonymous (2010) The 1991 bethesda system for reporting cervical/vaginal cytological diagnoses. Diagn Cytopathol 9:235–246 Anonymous (2010) The 1991 bethesda system for reporting cervical/vaginal cytological diagnoses. Diagn Cytopathol 9:235–246
12.
Zurück zum Zitat Bosch FX, Broker TR, Forman D et al (2013) Comprehensive control of human papillomavirus infections and related diseases. Vaccine 31(Suppl 5):F1CrossRefPubMed Bosch FX, Broker TR, Forman D et al (2013) Comprehensive control of human papillomavirus infections and related diseases. Vaccine 31(Suppl 5):F1CrossRefPubMed
14.
Zurück zum Zitat Davey E, Denton (2007) Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ 335:31–35CrossRefPubMedPubMedCentral Davey E, Denton (2007) Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ 335:31–35CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Akamatsu S, Kodama S, Himeji Y, Ikuta N, Shimagaki N (2012) A comparison of liquid-based cytology with conventional cytology in cervical cancer screening. Acta Cytol 56:370–374CrossRefPubMed Akamatsu S, Kodama S, Himeji Y, Ikuta N, Shimagaki N (2012) A comparison of liquid-based cytology with conventional cytology in cervical cancer screening. Acta Cytol 56:370–374CrossRefPubMed
16.
Zurück zum Zitat Girianelli VR, Thuler LC, Szklo M et al (2006) Comparison of human papillomavirus DNA tests, liquid-based cytology and conventional cytology for the early detection of cervix uteri cancer. Eur J Cancer Prev 15:504–510CrossRefPubMed Girianelli VR, Thuler LC, Szklo M et al (2006) Comparison of human papillomavirus DNA tests, liquid-based cytology and conventional cytology for the early detection of cervix uteri cancer. Eur J Cancer Prev 15:504–510CrossRefPubMed
17.
Zurück zum Zitat Kitchener HC, Gilham C, Sargent A et al (2011) A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer 47:864CrossRefPubMed Kitchener HC, Gilham C, Sargent A et al (2011) A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer 47:864CrossRefPubMed
18.
Zurück zum Zitat Ronco G, Cuzick J, Pierotti P et al (2007) Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 335:28CrossRefPubMedPubMedCentral Ronco G, Cuzick J, Pierotti P et al (2007) Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 335:28CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Low PS, Henne WA, Doorneweerd DD (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41:120–129CrossRefPubMed Low PS, Henne WA, Doorneweerd DD (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41:120–129CrossRefPubMed
Metadaten
Titel
Compare two different usages of FRD for detecting high-grade cervical lesions and invasive cancer
verfasst von
Yuping Dai
Lirong Wang
Donghong Li
Publikationsdatum
05.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2019
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-019-05078-z

Weitere Artikel der Ausgabe 5/2019

Archives of Gynecology and Obstetrics 5/2019 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.